Dna X (SONM) Total Liabilities (2018 - 2026)

Dna X has reported Total Liabilities for 9 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 86.71% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 86.71% YoY), and the FY2025 full-year result was $50.6 million, up 11.41% from the prior year.
• Total Liabilities for Q1 2026 stood at $4.9 million, down from $50.6 million in the prior quarter.
• The five-year high for Total Liabilities was $50.6 million in Q4 2025, with the low at $4.9 million in Q1 2026.
• Historically, Total Liabilities has averaged $32.4 million across 5 years, with a median of $33.6 million in 2022.
• Annual changes were most pronounced in 2025 — Total Liabilities surged 64.27% — and 2026, when it sank 86.71%.
• Dna X's Total Liabilities stood at $33.6 million in 2022, then gained by 0.1% to $33.7 million in 2023, then surged by 34.93% to $45.4 million in 2024, then grew by 11.41% to $50.6 million in 2025, then plunged by 90.28% to $4.9 million in 2026.
• The last three Total Liabilities figures came in at $4.9 million (Q1 2026), $50.6 million (Q4 2025), and $40.9 million (Q3 2025), per Business Quant data.